-
Date: December 14 to 16, 2022
The birth of conjugated drug (XDC) has opened up a new path for cancer treatment, and the slogan “everything can be conjugated” is gradually becoming into reality as the intertion of technology proceeding. How to make XDC drugs put into practices smoothly? TOT BIOPHARM joined hands with Tongxieyi to jointly plan a three-phase live broadcast series titled “R&D and Industrialization of Innovative Drug XDC Series”. Aiming on multiple aspects such as XDC drug R&D, drug registration, and formulation production, we will deeply analyze the entire process of XDC drug R&D and manufacture.